US Stock MarketDetailed Quotes
IPIX INNOVATION PHARMACEUTICALS INC
- 0.000500
- +0.000100+25.00%
15min DelayClose Nov 27 16:00 ET
259.17KMarket Cap-55P/E (TTM)
0.000500High0.000500Low29.92KVolume0.000500Open0.000400Pre Close14.96Turnover0.01%Turnover RatioLossP/E (Static)518.35MShares0.01950052wk High0.25P/B254.79KFloat Cap0.00000152wk Low--Dividend TTM509.59MShs Float0.540000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
INNOVATION PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 14.41%-677K | 66.46%-2.11M | 61.48%-369K | 58.16%-469K | 78.77%-477K | 59.52%-791K | 33.86%-6.28M | 63.18%-958K | 48.77%-1.12M | 29.43%-2.25M |
| Net income from continuing operations | 38.38%-880K | 55.01%-3.17M | 58.12%-681K | 53.03%-698K | 80.73%-361K | 30.54%-1.43M | 49.24%-7.04M | 36.61%-1.63M | 62.47%-1.49M | 69.66%-1.87M |
| Operating gains losses | 106.45%64K | 214.67%172K | 304.55%89K | --38K | --14K | --31K | ---150K | --22K | --0 | ---- |
| Depreciation and amortization | 1.08%94K | -2.36%373K | -3.13%93K | -2.11%93K | -2.08%94K | -2.11%93K | 1.06%382K | 1.05%96K | 0.00%95K | 2.13%96K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | -96.20%177K | ---- | ---- | ---- |
| Change In working capital | -87.46%42K | 183.33%310K | 168.09%126K | 46.88%94K | 45.56%-245K | 1,115.15%335K | 56.08%-372K | 127.33%47K | 117.58%64K | -333.16%-450K |
| -Change in prepaid assets | 73.91%40K | -91.71%29K | 1.69%-116K | 573.33%101K | -83.72%21K | -92.90%23K | 186.85%350K | 73.78%-118K | -61.54%15K | 1,390.00%129K |
| -Change in payables and accrued expense | -84.08%57K | 185.82%478K | 41.15%295K | -52.75%43K | 59.55%-218K | 212.58%358K | -82.03%-557K | -20.23%209K | 126.92%91K | -307.31%-539K |
| -Change in other current liabilities | -19.57%-55K | -19.39%-197K | -20.45%-53K | -19.05%-50K | -20.00%-48K | -17.95%-46K | -19.57%-165K | -375.00%-44K | 35.38%-42K | 29.82%-40K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 14.41%-677K | 66.46%-2.11M | 61.48%-369K | 58.16%-469K | 78.77%-477K | 59.52%-791K | 33.86%-6.28M | 63.18%-958K | 48.77%-1.12M | 29.43%-2.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 50.00%-2K | 98.53%-60K | 99.70%-12K | -183.33%-17K | 0.00%-27K | 76.47%-4K | -5,566.67%-4.08M | -21,110.53%-4.03M | 40.00%-6K | 32.50%-27K |
| Net intangibles purchase and sale | 50.00%-2K | 25.00%-60K | 60.00%-12K | -183.33%-17K | 0.00%-27K | 76.47%-4K | -11.11%-80K | -57.89%-30K | 40.00%-6K | 32.50%-27K |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | ---4M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 50.00%-2K | 98.53%-60K | 99.70%-12K | -183.33%-17K | 0.00%-27K | 76.47%-4K | -5,566.67%-4.08M | -21,110.53%-4.03M | 40.00%-6K | 32.50%-27K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 156.82%25K | -103.10%-123K | -41K | 3K | -104.14%-41K | -101.48%-44K | -71.09%3.97M | 0 | 0 | -76.23%990K |
| Net issuance payments of debt | 516.67%25K | 96.42%-37K | ---25K | --3K | 99.13%-9K | ---6K | -424.37%-1.03M | --0 | --0 | ---1.03M |
| Cash dividends paid | --0 | ---86K | ---16K | --0 | ---32K | ---38K | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | ---- | ---- | -0.22%5.01M | --0 | --0 | --2.02M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 156.82%25K | -103.10%-123K | ---41K | --3K | -104.14%-41K | -101.48%-44K | -71.09%3.97M | --0 | --0 | -76.23%990K |
| Net cash flow | ||||||||||
| Beginning cash position | -60.13%1.52M | -62.65%3.81M | -77.94%1.94M | -75.58%2.42M | -73.51%2.97M | -62.65%3.81M | 69.39%10.19M | -32.41%8.8M | 21.10%9.92M | 54.52%11.21M |
| Current changes in cash | 22.05%-654K | 64.16%-2.29M | 91.54%-422K | 57.14%-483K | 57.55%-545K | -182.91%-839K | -252.95%-6.39M | -77.00%-4.99M | -123.39%-1.13M | -236.45%-1.28M |
| End cash Position | -70.89%864K | -60.13%1.52M | -60.13%1.52M | -77.94%1.94M | -75.58%2.42M | -73.51%2.97M | -62.65%3.81M | -62.65%3.81M | -32.41%8.8M | 21.10%9.92M |
| Free cash flow | 14.59%-679K | 65.94%-2.17M | 61.44%-381K | 56.88%-486K | 77.84%-504K | 59.67%-795K | 33.52%-6.36M | 62.30%-988K | 48.73%-1.13M | 29.47%-2.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
